1 / 53

Diabetic Neuropathy in the Context of Diabetic Foot

Diabetic Neuropathy in the Context of Diabetic Foot. Podiatry Workshop Kuala Lumpur 18 – 19 November 2K Dr.Ashok Kumar Das Dean, Director, Prof. and Head Dept. of Medicine, JIPMER Pondicherry. Diabetic Neuropathy in the Context of Diabetic Foot - 2.

carys
Download Presentation

Diabetic Neuropathy in the Context of Diabetic Foot

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Diabetic Neuropathy in the Context of Diabetic Foot • Podiatry Workshop • Kuala Lumpur 18 – 19 November 2K • Dr.Ashok Kumar Das • Dean, Director, Prof. and Head • Dept. of Medicine, JIPMER • Pondicherry

  2. Diabetic Neuropathy in the Context of Diabetic Foot - 2 • DFU - cause for more amputation than any • other pathology. Is it inevitable? • St. Vincent’s and Health 21 WHO Declaration • have called for reduction in amputation in • diabetic foot. • Most contemporary and challenging issue

  3. Diabetic Neuropathy in the Context of Diabetic Foot - 3 • “5-10% of all diabetic patients have foot ulceration of various degrees and about 1% undergo amputation” • “Diabetes accounts for upto 50% of non traumatic leg amputations” • “Of all the diabetic amputees about 50% will lose their life or their other leg by 3 years”

  4. Diabetic Neuropathy in the Context of Diabetic Foot • Foot ulcers result in • *Morbidity • * Mortality • “Enormous health care expenditure” • “Psychosocial problems” • Paucity of data regarding prevalence of • diabetic foot in India

  5. Diabetic Neuropathy in the Context of Diabetic Foot - 5 • Neuropathy that is significant enough to cause foot ulceration may affect 40% of diabetic population especially elderly with type 2 diabetes.

  6. Indian Patients • Our major problem is neuropathic ulcer • 85 - 95 %, • 10 – 15% vascular. • -younger patients • -mean age of amputation earlier • - number of amputations for neuropathic ulcer

  7. Indian Context • Eminently preventable • Amputation in a diabetic neuropathic • ulcer is deplorable • Need of the hour • * Awareness/ education • * Early identification of a high risk foot • and its appropriate management

  8. Components of neuropathic foot transforming to diabetic foot - 1 • A. Ulcerative diabetic neuropathic foot • components • B. Non-ulcerative neuropathic pathologies in diabetic foot

  9. A. Components of ulcerative diabetic neuropathic foot - 2 • 1. Neuropathic foot and Neuroischaemic foot • 2. Neuropathic foot deformities • a. Clawed toes • b. Pes cavus • c. Hallux rigidus and valgus • d. Hammer toe • e. Nail deformities • f. Charcot foot

  10. A. Components of ulcerative diabetic neuropathic foot - 3 • 3. Neuropathic callus • 4. Neuropathic oedema • 5. Neuropathic ulcers • a. Callus ulcers • b. Ulcer over the pressure points on the sole • c. Decubitus ulcers • d. Puncture wound ulcers • e. Traumatic ulcers

  11. B. Non-ulcerative neuropathic pathologies in diabetic foot • 1. Charcot Foot • Acute, chronic bone destruction and • deformed diabetic foot and toes • 2. Pathological fractures • 3. Diabetic painful neuropathy

  12. DN in context of diabetic foot - 1 • Our job – look after “NDF at risk” • A: Preventive measures • Treatment rapid and intensive • Rest • Off load • Antibiotics • Foot wear • Patient education

  13. DN in context of diabetic foot - 2 • B. Metabolic control • Hyperglycemia • Hypertension • Hyperlipidaemia • Cessation of smoking • C. Deformity management • D. Callus management • E. Debridement and dry skin and fissure • management

  14. DN in context of diabetic foot - 3 • F. Mechanical control • Off load, Off load, Off load • by rest, crutches, walkers, protective shoes, heel protective pad, decrease plantar pressure by removal callus • G. The importance of callus removal in NFU • decrease plantar pressure • know full dimension of the ulcer • deep swab • drainage of exudate, removal of dead tissue • H. Infection control • I. Educational control

  15. Diabetic neuropathy Scope of the syndrome - 1 • Three components of neuropathy: • *sensory – painful, painless • *Motor • *Autonomic • All contribute to diabetic foot ulceration • Asymptomatic neuropathy 35%

  16. Diabetic neuropathy Scope of the syndrome - 2 • Diffuse • 1. Distal symmetric sensorimotor • polyneuropathy • 2. Autonomic neuropathy • A.Sudomotor • B.Cardiovascular • C.Gastrointestinal • D.Genitourinary

  17. Diabetic neuropathy Scope of the syndrome - 3 • Focal • 1.Cranial neuropathy • 2.Radiculopathy/plexopathy • 3.Entrapment neuropathy • 4.Asymmetric lower limb motor • neuropathy- Diabetic amyotrophy

  18. Diabetic neuropathy Scope of the syndrome - 4 • Rather than acting in isolation neuropathy • exerts • Its vicious effects in concert with • angiopathy + immunopathy leading to • infections

  19. Neuropathic foot components • Neuropathic ulcer • Neuropathic joint • Neuropathic oedema

  20. Diabetic foot – Mechanisms - 1 • Loss of pain sensation results in • neuropathic injury due to • repeated unrecognised trauma • inflicted in many different ways

  21. Diabetic foot – Mechanisms - 2 • Loss of joint positon sense results • in abnormal foot posture • This may lead to injury when • the shoes are not properly selected • or during walking

  22. Diabetic foot – Mechanisms - 3 • Motor Neuropathy • * Weakness • * Wasting of small intrinsic muscles of • foot • *Imbalance between the flexor and extensor muscles

  23. Diabetic foot – Mechanisms - 4 • Intrinsic deformity • Clawing of the toes • Prominence of metatarsal heads • Flattening of the arch

  24. Diabetic foot – Mechanisms - 5 • Abnormal distribution of body weight • Weight gets concentrated on smaller • areas like metatarsal head and the heel. • Excess pressure loading of these areas • finally results in callus formation.

  25. Diabetic foot – Mechanisms - 6 • Body weight in patients with plantar ulcers • was significantly greater than in those • with neuropathy but no ulcer.

  26. Autonomic neuropathy - 1 • * Damages the sympathetic innervation of lower limb • * This results in • Decreased sweating • Results in dry skin fissures / cracks • Super added infection

  27. Autonomic neuropathy - 2 • Opening of arteriovenous channels • Warm skin ( misleadingly healthy ) • Shunting of nutrients and oxygen from • the tissues • Impaired vascular response to infection

  28. Autonomic neuropathyclassical signs • Dry skin with fissuring • Distended veins over the dorsum of foot • and the ankle

  29. Connective tissue changes • Hyperglycemia causes non enzymatic • glycation of collagen and keratin • Increase in cross linking • Become rigid and inflexible • Tissue break down in places where there • is high horizontal shear force

  30. Neuropathic ulcer • * Painless • * Develops on pressure points (metatarsal heads/heel) * Pulsations intact unless superadded ischaemia is also present * Decrease in pain / temperature as also in the • vibration perception • * Punched out ulcer surrounded by callus

  31. Neuropathic (n) /Ischemic ulcer (i) • Site Pressure points (n) • Sides / tips of toes (i) • Pain --- ( n ) +++ ( i ) • Callus ++ ( n ) --- ( i ) • Pulse ++ ( n ) --- ( i ) • Abi > 1 ( n ) < .6 ( i ) • Healing ++ ( n ) --- ( i )

  32. Quantitative tests for neuropathic assessement - 1 • 1. Measurement of light touch sensation • - Nylon monofilament (Semmes • Weinstein) • 2. Measurement of thermal sensitivity • - Marstock Thermode

  33. Quantitative tests for neuropathic assessement - 2 • The advantage of the assessment with monofilaments or biosthesiometry is the detection of whether the patient has lost protective pain sensation that would render him susceptible to foot ulceration. • Nylon monofilaments test the threshold to pressure sensation

  34. Quantitative tests for neuropathic assessement - 3 • Monofilament: This is a simple technique. • When applied perpendicular to the foot it • buckles at a force of 10 gms • Areas to be tested include plantar aspect • of big toe metatarsal heads of first, third • and fifth and the plantar surface of heel. • Filament not to be applied over the callus

  35. Quantitative tests forneuropathic assessement - 4 • 1. Measurement of vibration • *Biosthesiometer • *Graduated tuning fork • 2. Nerve conduction studies

  36. Management of Neuropathic Ulcer - 1 • General measures • Specific measures

  37. Management of Neuropathic Ulcer - 2 • Good glycemic control • Treatment of infections • Management of neuropathic oedema

  38. Management of Neuropathic Ulcer - 3 • All ulcers irrespective of their cause will be slow to heal in presence of oedema, due impairment of local flow • Neuropathic oedema can be treated with • Diuretics • Ace inhibitors • Ephedrine ( 30 mg tds ) • D/d hypo albuminemia cardiac failure

  39. Management of Neuropathic Ulcer - 4 • “Over 90% of predominantly neuropathic • ulcers will heal satisfactorily with • conservative measures”

  40. Management of Neuropathic Ulcer - 5 • “Key to the management is the relief of • pressure that caused the initial lesion” • Pressure is off loaded most effectively by • encasing the foot in a light plaster of paris • cast. • *Total contact cast • *Removable scotch cast boot, custom made shoes etc.

  41. Preventing Neuropathic Foot Ulcers - 1 • Regular inspection of foot - annually • Identification of high risk feet – 3 mo / 6mo • Careful choice of foot wear • Regular chiropody • Intense education

  42. Preventing neuropathic foot ulcers - 2 • “As little as one hour’s education provided by the podiatrist resulted in 70% reduction in amputations over the following 2 years . as compared with a control group who did not receive the advice” • Malone IM et al 1989

  43. Glycemic control and diabetic neuropathy • Diabetes control and complication trial • showed that intensive insulin therapy • reduced the incidence of appearance of • neuropathy by about 70%

  44. Intensive insulin treatment • Reduced the clinical appearance of overt • neuropathy in patients with subclinical • neuropathy from 16% to 7% (57% • reduction) • Reduced the risk of developing clinically • overt diabetic neuropathy by 60% over five • years

  45. Neuropathic joint or Charcot arthropathy - 1 • 1868 French neurologist I.M. Charcot • First described in tabes • Can also be seen in leprosy, • syringomyelia, • hereditary sensory neuropathy, • Charcot Marie Tooth disease etc

  46. Neuropathic joint or Charcot arthropathy - 2 • Relatively rare • Potentially devastating disorder • Long standing diabetes • Dense peripheral neuropathy • Peripheral vascular disease is typically • absent

  47. Neuropathic joint or Charcot arthropathy - 1 • Sympathetic failure-- increased blood • flow due to arteriovenous anastomosis • Bone demineralisation (diabetic • osteopenia) • Susceptibility to minor, recurrent fractures

  48. Neuropathic joint or Charcot arthropathy - 4 • Painless disintegration of bone in • response to trivial trauma • Common joints involved are • Tarso metatarsal • Metatarso phalangeal • Ankle joint • Knee joint

  49. Neuropathic joint or Charcot arthropathy - 5 • Acute Charcot arthropathy may mimic infection • Chronic Charcot foot is classically described as ‘bag of bones’ • (Gross destruction of joint surfaces and bone with effusion which is typically painless)

  50. Neuropathic joint or Charcot arthropathy - 6 • Differentiation from osteomyelitis is • difficult • * TC 99 Scan • * Indium labelled white cell scan • * MRI

More Related